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Abstract
Background: Geographical variations in medical practice are expected to be small when the evidence about the
effectiveness and safety of a particular technology is abundant. This would be the case of the prescription of
conservative surgery in breast cancer patients. In these cases, when variation is larger than expected by need,
socioeconomic factors have been argued as an explanation. Objectives: Using an ecologic design, our study aims
at describing the variability in the use of surgical conservative versus non-conservative treatment. Additionally, it
seeks to establish whether the socioeconomic status of the healthcare area influences the use of one or the other
technique.
Methods: 81,868 mastectomies performed between 2002 and 2006 in 180 healthcare areas were studied.
Standardized utilization rates of breast cancer conservative (CS) and non-conservative (NCS) procedures were
estimated as well as the variation among areas, using small area statistics. Concentration curves and dominance
tests were estimated to determine the impact of income and instruction levels in the healthcare area on surgery
rates. Multilevel analyses were performed to determine the influence of regional policies.
Results: Variation in the use of CS was massive (4-fold factor between the highest and the lowest rate) and larger
than in the case of NCS (2-fold), whichever the age group. Healthcare areas with higher economic and instruction
levels showed highest rates of CS, regardless of the age group, while areas with lower economic and educational
levels yielded higher rates of NCS interventions. Living in a particular Autonomous Community (AC), explained a
substantial part of the CS residual variance (up to a 60.5% in women 50 to 70).
Conclusion: The place where a woman lives -income level and regional policies- explain the unexpectedly high
variation found in utilization rates of conservative breast cancer surgery.
Background
Breast cancer represents 30% of all cancers in Spain and
is the most common tumor in women, responsible for
very high morbidity and mortality rates. About 16,000
cases are diagnosed annually in the country representing
a death burden of almost 6,000 women [1]. Early detec-
tion programs along with diagnostic and therapeutic
advances have raised survival rates five years after diag-
nosis over 75% [2].
The current therapeutic approach for breast cancer
includes surgery, followed by hormonal therapy and
radiotherapy. Surgical treatment can be conservative
(CS), which preserves part of breast glandular tissue, or
non-conservative treatment (NCS) which entails total
removal of breast glandular tissue, maintaining or not
the skin tissue.
Different studies [3-6] show equal effectiveness for
both surgical strategies in terms of long-term survival.
In fact CS is recommended, at any stage of breast can-
cer [5,6], confining the use of NCS to those situations
where the tumor’s size relative to total breast mass pre-
vents conservative resection.
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pointed out differences in the use of surgical techniques
[7-11]. Socioeconomic factors such as poverty, educa-
tional level, urbanity and race, showed strong associa-
tion to the use of CS. However, the analysis of this
variability and its underlying factors is still pending in
the Spanish context.
Our work therefore aims to describe the variability in
the use of conservative surgery versus the non-conserva-
tive option in patients with breast cancer in Spain; the
goal is to establish whether there is any relationship
between the techniques used and health care areas’
socioeconomic level, ruling out alternative explanations.
Methods
Design
Ecologic descriptive study of geographic variations in
the rates of CS versus NCS in breast cancer, and the
association between them and the socioeconomic level
of the health care areas.
Population and setting
Object of analysis were 180 health care areas of 16
Autonomous Communities (ACs) participating in the
project Atlas of Variations in Medical Practice in the
National Health System [12]. These 180 areas comprised
a female population in annual average between 2002 and
2006 of 16,269,475 women over 15 years old.
We selected all discharges with female breast cancer
recorded in the Hospital Discharge Administrative Data-
base (HDAD) between the years 2002 to 2006. Of these,
we selected those episodes in which breast surgery had
been performed. Cases were classified according to
whether they had received CS or NCS. In order to
achieve consistency in the operational definitions a
g r o u po fs u r g e o n se x p e r ti nb r e a s ts u r g e r y ,s o r t e dt h e
corresponding ICD 9
th MC surgical procedures codes
into CS and NCS. Table 1 shows the resulting opera-
tional definitions.
Being a geographical study (examining population
rather than individual exposure to procedures), breast
cancer interventions were assigned to the patient’sg e o -
graphic area of residence regardless of the hospital
where they were operated. These cases constituted the
numerator of the rates and the female population in
each area was the denominator [12].
Main endpoints
Standardized CS and NCS rates for women over 15
years old were calculated as well as the specific rates in
three age groups (from 15 to 49, 50 to 69 and 70 and
over). The intermediate age-group was chosen to repre-
sent the women targeted for population breast cancer
screening in Spain (50 to 70 years). The age
Table 1 Breast cancer surgery ICD 9th codes and definitions
Breast cancer 174
Malignant neoplasm of female breast
174.0
Nipple and areola
174.1
Central portion
174.2
Upper-inner quadrant
174.3
Lower-inner quadrant
174.4
Upper-outer quadrant
174.5
Lower-outer quadrant
174.6
Axillary tail
174.8
Other specified sites of female breast
174.9
Breast (female), unspecified
233.0
Carcinoma in situ breast
V10.3
Breast. History of conditions classifiable to 174
and 175
Conservative
mastectomy
85.20
Excision or destruction of breast tissue, not
otherwise specified
85.21
Local excision of lesion of breast
85.22
Resection of quadrant of breast
85.23
Subtotal mastectomy
Non conservative
mastectomy
85.33
Unilateral subcutaneous mammectomy with
synchronous implant
85.34
Other unilateral subcutaneous mammectomy
85.35
Bilateral subcutaneous mammectomy with
synchronous implant
85.36
Other bilateral subcutaneous mammectomy
85.41
Unilateral simple mastectomy
85.42
Bilateral simple mastectomy
85.43
Unilateral extended simple mastectomy
85.44
Bilateral extended simple mastectomy
85.45
Unilateral radical mastectomy
85.46
Bilateral radical mastectomy
85.47
Unilateral extended radical mastectomy
85.48
Bilateral extended radical mastectomy
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applying as reference the female population registered in
the 2003 census for all the health areas.
Independent socioeconomic variables
1) The “economic level” is understood as an index of
average family income available per capita (income from
work, capital income, social benefits and transfers,
minus direct taxes paid by families and the fees paid to
social security). This variable was stratified into 10 cate-
gories (1: <7,200 Euros; 2: 7,200 to 8,300; 3: 8,300 to
9,300; 4: 9,300 to 10,200; 5: 10,200 to 11,300; 6: 11,300
to 12,100; 7: 12,100 to 12,700; 8: 12,700 to 13,500; 9:
13,500 to 14,500 and 10:> 14,500)
2) The “educational level” is understood as the percen-
tage of college graduates within the total population.
Spain municipalities’ Economic Yearbook 2005 [13]
was the source of up to date data for economic level
(2003) and educational level (2001). Each area’s eco-
nomic and educational levels were calculated as popula-
tion weighted averages of the values registered for each
municipality included in a healthcare area.
Alternative explanatory factors
1) Availability of high technology: living in an area
served by a tertiary hospital or by a hospital delivering
radiotherapy services could have an impact on the elec-
tion of conservative vs non-conservative surgery; the
absence of these services in the neighbouring facilities
would entail regularly travelling to the closest centre
providing adjuvant therapy which might be bothersome;
that could be specially true in elder women [11].
Hypothetically, those areas served by “high-tech” hospi-
tals should show higher rates of conservative (vs non-
conservative) surgery. The 2003 National Survey of
Inpatient Care Premises (ESCRI) [14] provided the tech-
nology availability data needed to study this potential
association.
2) “Autonomous community of residence” will be con-
sidered as a surrogate of regional policies (i.e. breast
cancer screening).
Due to the fact that the Spanish National Health Sys-
tem is organized in ACs with full responsibility on plan-
ning and implementation of specific intervention
programs [e.g., breast cancer screening], it is expected a
cluster effect explaining part of the variation on surgery
rates.
Analysis
To determine the magnitude of the systematic variation
between rates (beyond chance and differences in popula-
tion structure), the usual small area analysis statistics
were calculated [12]: ratio of variation (RV), systematic
component of variation (SCV) and Empirical Bayes
statistic (EB) [15]. In the case of RV, in order to reduce
random noise, only the areas between 5 and 95 percen-
tile of the corresponding rates distribution were used
for the estimation.
The association between intervention rates and the
socio-economic level (economic and educational level)
of the area, was established calculating the concentra-
tion index and graphically represented drawing concen-
tration curves. Likewise, the level of dominance of each
concentration curve was determined by comparing it to
the diagonal line of 45°. The concentration curve shows
the surgery rates (CS and NCS) ordered by area income
(growing). A concentration curve falling below the diag-
onal (concentration index >0) indicates that surgery
rates are less concentrated in the first population group
(lower quintiles of economic level) and more concen-
trated in the last population groups (higher quintiles of
economic level). Conversely, a concentration curve
located above the diagonal (concentration index < 0)
indicates that surgical rates are more concentrated in
the first population groups (lower economic level) and
less concentrated in the last population groups (higher
economic level) [16,17].
The effects of high technology availability and regional
policies, were studied using ANOVA analysis (bivariate
analysis) followed by mixed-effects linear multilevel hier-
archical models. The best model was selected on the
basis of the likelihood ratio with a 5% threshold on
alpha error. Rho statistic and its confidence interval
were estimated to determine the amount of variation
explained by the second level (ACs) once first level vari-
ables (demography, socioeconomic status, supply fac-
tors) were adjusted [18,19].
All analyses were performed using STATA 10 [19]
and DASP [20] software.
Ethics
The study, observational in design, uses retrospective
data from administrative databases in where patients are
anonymous to the researchers. The study did not
require informed consent nor Ethics Committee
approval.
Results
A total of 81,868 breast cancer interventions were per-
formed across all the age groups: 44,648 were CS and
38,067 NCS. The corresponding standardized rates
amounted to 5.29 and 4.84 interventions for every
10,000 women; this implies an overall 9.3% more utiliza-
tion of conservative surgery.
Figure 1 and Table 2 show the variability in the inter-
vention rates across healthcare areas. The statistics
detect large variability in utilization of CS: in terms of
variation, the areas in the upper side of the distribution
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those in the lower end; in turn, NCS shows more mod-
erate levels of variability with a ratio around 2 between
the areas with highest and lowest utilization; in SCV
terms, systematic variation (beyond random) was 1.91
times higher in the case of conservative surgery com-
pared to non-conservative interventions.
The analysis by age group quite follows the same
trend depicted by the overall figures. CS is more fre-
quently used (always showing higher variation across
healthcare areas than NCS) except in the group 70 years
and older; among elder women the NCS utilization rate
is clearly above the CS (table 2). In SCV terms, systema-
tic variation is larger in conservative surgery; particu-
larly, in the age group below 50 years old, showing a 3.3
times higher systematic variation in conservative techni-
ques (1.37 higher for women between 50 and 70 years
old and 1.9 for women above 70).
Applying the Empirical Bayes analysis (more robust
statistics), systematic variation in CS is still higher than
 
Figure 1 Variation in conservative vs non conservative breast cancer surgical rates 2002 - 2006 log standardized rates by age group.
CS: conservative surgery; NCS: Non-conservative surgery. Each dot represents a healthcare area standardized rate per 10,000 women.
Table 2 Conservative and non conservative breast cancer surgical rates
Less than 50 years 50 to 70 years More than 70 years All ages
CS NCS Total CS NCS Total CS NCS Total CS NCS Total
Cases 11,821 9,646 21,251 23,204 14,676 35,523 9,623 13,745 23,094 44,648 38,067 81,868
Population 47,728,827 19,931,718 13,945,734 81,606,279
Standardized rate 2.40 2.05 4.41 11.13 7.69 18.67 6.81 10.30 16.91 5.29 4.84 10.03
RV5-95 4.17 2.76 2.45 3.97 2.98 2.32 7.16 2.909 2.50 3.92 2.51 2.05
SCV 0.141 0.042 0.046 0.148 0.108 0.062 0.236 0.122 0.083 0.153 0.080 0.057
Empirical Bayes 0.149 0.064 0.048 0.182 0.101 0.061 0.272 0.091 0.067 0.191 0.078 0.059
2002-2006 age-sex standardized rates and statistics of variation
CS: Conservative surgery; NCS: Non-conservative Surgery. RV5-95: Represents the range of variation in standardized rates, between the areas in percentiles 95
th
and 5
th, expressed as a ratio. Systematic Component of Variation (SCV)) and Empirical Bayes Statistic (EB) represent the variation considered systematic (thus,
beyond chance). Both are estimated using observed and expected cases; the latter obtained by indirect standardization.
EB uses Bayesian modelling and simulation, resulting in a more robust estimate for small numbers [15].
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pattern of Bayesian statistics was consistent with the
results of the initial analysis, with the two types of sur-
gery showing the same behavior across age groups, and
consistently different between themselves.
As for the association between socio-economic vari-
ables and types of surgical interventions, the concentra-
tion index observed for the NCS was systematically
negative, while systematically positive for CS (table 3
and figure 2). These results mean that those areas with
higher economic and educational levels show higher
rates of CS, regardless of the age group, while areas
with lower economic and educational levels showed
higher rates of NCS interventions. These differences in
socio-economic variables were statistically significant
when compared to line 45° only in the case of CS. Parti-
cularly, the economic level was significant in analyzing
any age group; in turn, the educational variable proved
significant when analyzing the total population and the
medium-age group (50 to 70 years old) but not for the
younger and elder women. [Additional file 1]
With regard to the effect of living in an area served by
“high-tech” hospitals, neither the existence of a tertiary
centre nor the availability of radiotherapy services within
the area had any statistically significant effect on differ-
ences in surgery rates. Only a slightly higher rate of CS
was observed in the 50 to 70 age group in areas served
with radiotherapy (12 vs 10.8 per 10,000 women); in
turn, a slightly higher rate of NCS was found in the
elder group, in those areas without radiotherapy service
(10.6 vs 9.5 per 10,000 women). [Additional file 1]
The multilevel analysis for CS discarded the educa-
tional level variable and only economic level was
retained in the model. When the cluster effect of the
autonomous community was incorporated into the ana-
lysis, it accounted for 34.7% of the residual variation for
all women (Confidence Interval, CI, 95%: 16.9%-58.2%).
Analysing by age groups, it can be observed how AC
accounted for up to 23% of residual variation in the
case of women below 50 years old (CI95%: 6.8% to
55.2%), 36.7% in the case of women between 50 and
70 years old (CI95%: 18.1% to 60.5%) and 25.9% in the
case of women older than 70 years (CI95%: 13.6% to
43.7%). Income availability in the area and the AC of
residency did not show interaction. [Additional file 2]
As for the NCS multilevel analysis, neither educational
nor economic variables remained in the model, confirming
the expectation suggested by the results of the bivariate
analysis. In this case the AC (second level) barely
explained a 3.5% of the variation in all women (CI95%:
0.06% to 65.5%). In turn, it explained a small part of the
residual variation in the youngest group of age, 14%
(CI95%: 4.5% to 35.7%), up to a 4.9% (CI95%: 0.5% to
34.8%) in the case of women between 50 and 70 years old,
and 1% of residual variation (CI95%: 0.001% to 87%) in the
case of women above 70 years old. [Additional file 2]
Discussion
This ecological study on CS vs. NCS utilization, in 180
Spanish healthcare areas, has shown that: a) there are sys-
tematic variations in the use of these surgical procedures
that are not amenable to population age structure; b)
The use of CS is growing but in an uneven fashion incon-
gruent with its being an effective surgical treatment for
breast cancer; utilisation rates are highly dependent upon
economic level in the area regardless the age group ana-
lyzed; affluent areas show consistently higher CS rates
while poorer areas yield consistently higher NCS rates; c)
supply of high technology (radiotherapy services within a
healthcare area) was not related to differences in CS or
NCS rates; and, d) Regional policy (i.e. breast cancer
screening programs) behaves as an independent factor in
explaining the use of one or another surgical procedure.
A good part of the detected variation in the use of CS
was explained by economic level and regional policy (AC);
this construct seems to be especially effective in explaining
CS variations for women aged 50 to 70. In the case of
NCS, the AC explained a small part of the variance.
Consistency with previous knowledge
These results show some level of incongruence, with
what was expected for this type of procedure. According
Table 3 Concentration index values for conservative and non conservative surgery
Age-groups Concentration Index ranked by income (CI95%) Concentration Index ranked by educational level (CI95%)
All years CS 0.12 (0.09 to 0.14) ‡ 0.05 (0.01 to 0.09) ‡
All years NCS -0.03 (-0.05 to -0.007) ‡ -0.02 (-0.04 to 0.001)
< 50 years CS 0.10 (0.07 to 0.14) ‡ 0.04 (0.01 to 0.08) ‡
< 50 years NCS -0.02 (-0.05 to -0.002) ‡ -0.01 (-0.03 to 0.01)
50-70 years CS 0.12 (0.09 to 0.15) ‡ 0.05 (0.01 to 0.10) ‡
50-70 years NCS -0.04 (-0.06 to -0.01) ‡ -0.02 (-0.05 to 0.01)
> 70 years CS 0.13 (0.09 to 0.17) ‡ 0.04 (-0.02 to 0.11)
> 70 years NCS -0.02 (-0.04 to 0.006) -0.02 (-0.05 to 0.007)
CS: Conservative Surgery; NCS: Non-conservative surgery. CI95%: Concentration index confidence interval assuming a type I error of 5%. ‡ Statistical significance
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Figure 2 Concentration curves for conservative and non conservative surgery by age-group, area income and area educational level.
X axis represents quintiles of the distribution of socioeconomic level; y axis represents quintiles of the distribution of rates of surgery. Solid line
represents conservative surgery. Dashed line represents non conservative surgery. Explanation: the level of dominance of each concentration
curve is determined by comparing it to the diagonal line of 45°. If the concentration curve is below the diagonal (concentration index >0), it is
indication that surgery rates are less concentrated in the first population group (lower economic level) and more concentrated in the last
population groups (higher economic level). If the concentration curve is located above the diagonal (concentration index < 0) it indicates that
surgical rates are more concentrated in the first population groups (lower economic level) and less concentrated in the last population groups
(higher economic level).
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graphical variations of medical practice [21], effective
and safe procedures should have low variability, lower
than those procedures in which the risk-benefit balance
is less certain. There is a high level of consensus sup-
porting the indication of surgery for diagnosed breast
cancer. Recent evidence points out how in Spain the
variability in the use of mastectomy is among the lowest
for cancer related procedures [22]. Focusing on the two
options (conservative and non-conservative), the evi-
dence-based recommendation for the use of CS prevails
over NCS, the size of the tumor being the only limiting
factor. However, a higher variation in the use of CS has
been observed compared to NCS; this holds even in
cases where variation was completely unexpected, such
as the age group between 50 and 70 years; being the tar-
geted population for existing screening programs, these
women have a higher probability of early detection and
thus smaller size at diagnosis.
On the other hand, regarding the effect of socio-eco-
nomic variables, the results of this study are consistent
with other studies. Gilligan [7] highlights, how 10 years
after the publication of the first trials on CS-NCS,
socio-demographic factors, such as per capita income
levels and education, still influence the use of CS versus
NCS and thus women who reside in more deprived
areas have a higher probability of not receiving CS. The
authors affirm that the explanation should not be sought
in differing levels of medical knowledge but rather in
different levels of access to medical care. In addition,
Smith [10] detects considerable geographic variations in
the use of CS notwithstanding the overall increasing
tendency to use CS instead of NCS in the USA; accord-
ing to their results, 70% of the women susceptible of
mastectomy were treated with CS in the Northeast
region of USA (wealthier areas) against a 50% in the
south of the USA (less affluent areas).
Finally, the observed AC cluster effect is congruent
with the role of ACs in planning and implementing
screening policy. Existing evidence on breast cancer
screening programs across Spain points out the differ-
ences on degree of implementation, design and coverage
for the period of analysis [23]. Such differences could be
argued as relevant in explaining the detected regional
effect: effective early detection translates into smaller
size of the tumor, thus discarding the primary indication
for NCS. In Spain the target population for screening is
women between 50 and 70 years old; therefore, the
impact of the regional factor in this age group can be
expected to be relevant. In fact, AC of residence
explained up to a 60% of the residual variation in this
age-group.
Unfortunately comparable data about the characteris-
tics of each of those regional screening programs are
scarce. A thorough analysis of the characteristics of the
regional breast cancer screening programs [24] con-
cluded that the information systems supporting them
were too heterogeneous to allow for sounded compari-
sons across ACs; as the authors plead, only standardized
definitions and enhanced systematic data collection
would enable the benchmarking of the relevant aspects
of screening programs (both results and strategy).
Nevertheless, in an attempt to test the suggested
hypothesis an exploratory analysis was conducted using
two of the indicators collected in the aforementioned
study: adherence to the screening program among tar-
geted women and rate of T1 tumors detected [24]. The
analysis showed how those regions achieving higher
adherence among targeted women registered higher
rates of CS (Spearmann coefficient = 0.52; p = 0.04). In
turn, and more specifically, the higher the effectiveness
of a regional screening program in detecting T1 tumors,
the higher the CS rates registered in the AC (Spearmann
coefficient = 0.87; p < 0.001). Though revealing, given
the weakness of the data, no conclusions can be drawn
from these findings on the precise nature of the effect
of regional policy on the variability in mastectomy mod-
ality and further analysis is warranted.
Alternative explanations for the obtained model
Several factors besides age, population income and AC
o fr e s i d e n c es h o u l db ec o n s i d e r e da sa na l t e r n a t i v e
explanation to the CS rates variability. The following
paragraphs will discuss whether the impact of these fac-
tors might alternatively explain our findings.
Do differences in tumors size explain the differences in
rates?
According to evidence the key factor in deciding the use
of CS is the tumor size [6,11,25]. Arguably high CS
rates might not depend upon age or high income, but
on higher proportions of smaller tumors in those areas
with higher CS rates. Unfortunately this information
item (i.e. tumor status “T”) is not available in hospital
administrative databases or in cancer population-based
regional registries across the country. Therefore differ-
ences in the T1-T4 case-mix among areas are unknown.
However, we could reasonably argue that since the
prevalence of small tumors is highly dependant on the
screening effectiveness (therefore regional policies), the
lack of data on tumor size and the eventual differences
in T1-T4 case-mix across areas are dealt with once
autonomous community cluster effect is included in the
models.
Are there differences across healthcare areas regarding the
speed of adoption of conservative surgery technology?
Due to the nature of the study, a cross-sectional study,
another alternative explanation for the observed varia-
tion in utilization rates relies on eventual differences in
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care areas. After examining the evolution in utilization
between 2002 and 2006, we observed an overall increas-
ing trend in the use of CS compared to NCS, more pro-
nounced for the group of women aged 50 to 70 years.
The ad hoc joint point analysis performed [26,27] con-
firmed a statistically significant trend change in 2004
favoring the utilization of CS [additional file 3].
Nevertheless, a concurrent study [28] looking specifi-
cally at the adoption patterns of CS in two of the Span-
ish Autonomous Communities (including 40% of
healthcare areas of our work) showed no differential
paces in the adoption of CS techniques between the two
ACs, minimizing the possibility of speed of adoption as
an alternative explanation.
An additional argument for discarding differential
speed of adoption comes hand by hand with the results
obtained in analyzing the impact of proximity to tertiary
hospitals and radiotherapy premises. CS adoption is clo-
sely related to innovative environments; the high tech
supply factors included in the analysis can be reasonably
considered as surrogate variables for adoption speed.
Since, none of these supply variables showed any rela-
tionship with CS rates, we do not expect adoption speed
to provide an alternative explanation to the variability
detected.
Unaccounted Factors
As noted, the adjusted models left a significant propor-
tion of unexplained residual variation. Some factors not
included in the analysis, may contribute to explain the
unaccounted variance. The availability of plastic sur-
geons during surgery, local learning cascades [29,30],
recommendations by leading surgeons and oncologists
[31-33] and patients’ differential preferences (particularly
for women under 50 and older than 70 years) [34,35]
have been highlighted as relevant factors in the litera-
ture. The eventual different geographical distribution of
any of these factors may play a role in explaining the
detected variation in utilisation rates across healthcare
areas.
The supply-related set of factors (availability of plastic
surgeons or learning cascades) can be logically clustered
together into “innovativeness of the environment”.A s
argued in the case of speed of innovation adoption, no
association has been detected between living in an area
served by a “high tech centre” and the risk of receiving
either type of surgery.
Regarding the last factor it is worth noting that
patients’ preferences are usually linked to education.
Remarkably, population education level did not remain
in the models, showing low power in explaining variation.
Summarizing: age, socioeconomic status and regional
policies explain differences in the surgical approach at
population level. Those potential alternative explanations
like tumor size differences, speed in adoption of innova-
tions and non studied supply and demand factors, seem
to be controlled through the variables used as indepen-
dent predictors of variation.
Study Limitations
Design Type
Among the limitations of this study must be mentioned
firstly, those inherent to its ecologic design: the detected
socioeconomic gradient in intervention rates across
healthcare areas prevents drawing conclusions about
individual access to healthcare driven by their economic
levels (ecological fallacy). However, as noted earlier,
individual-based studies reached the same conclusions
regarding the socioeconomic impact on CS rates.
Selection bias
The study only included data from hospitals within the
public utilization network. If private hospitals were to
perform more CS, the inclusion of private hospitals
would have yielded different results as to the estimated
intervention rates and the age and economic effects
detected. The single study available in Spain comparing
the use of CS vs NCS in public and private hospitals
[28] refers to the AC of Catalonia where the private sec-
tor is stronger compared to the rest of the territory.
They found lower CS use rates in private hospitals com-
pared to public ones. At the light of these findings an
eventual underestimation of CS utilization rates in more
affluent areas (more privately served) is unlikely; in any
case, the inclusion of private hospitals data would only
reinforce the detected economical gradient.
Another potential source of selection bias in popula-
tion studies comes from the coverage of the administra-
tive data bases used. In theory, areas showing low levels
of mastectomy could be denoting poor coverage in the
registration of discharges rather than actual lower use of
surgical procedures. However, the hospital discharges
database used in this study registers above 95% of the
actual discharges in all ACs [22].
A third possible source of error is linked to the suc-
cess in assigning mastectomy cases to the place of resi-
dence (the base of the study is geographical and patients
are analyzed according to their place of residence). Sys-
tematic variability in the proportion of successful assign-
ment across geographical units would pose some doubts
about underlying bias. Previous studies using this same
cancer administrative data in Spain [22], showed assign-
ment rates above 95% of the cases and homogeneous
achievement across the territory. Therefore this source
of error would not affect this study results.
Miss-classification of cases due to the ICD9th definitions
In using hospital discharges administrative databases
(HDAD), cases are necessarily defined by ICD codes (in
Spain ICD9-CM). This “language” do not allow for
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tion in the same breast and intervention on the contralat-
eral breast. This limitation creates a risk of double
counting and case misclassification (e.g., initial CS fol-
lowed by NCS due to recidive in the same breast or new
CS for the contralateral breast). If misclassification were
important, it would be necessary to consider whether it
affects CS rates in a different manner across healthcare
areas since the second intervention due to recidive will
be less conservative. A Spanish study, in which the
HDAD was compared with 4 population cancer regis-
tries, showed that, in the particular case of breast cancer
(using the same definition applied for this study), the
positive predictive value for the HDAD definition was
above 80% [36]. The percentage of cases that could be
considered as “misclassified”, being recidive or contralat-
eral breast interventions were only one in 100,000 people.
Conclusion
As observed, living in a certain healthcare area or politi-
cal demarcation of the country, affects the probabilities
of a woman receiving one type of surgery or the other.
In the case of CS, this probability is also influenced by
the economic level of the population living there.
The revision of breast cancer screening programs’
characteristics and the assessment of effective access to
them in certain deprived areas is critical to reduce the
detected underutilization of CS in certain places. In
turn, smaller tumors once detected, will require timely
availability of CS, whichever the socioeconomic status of
the served population.
According to the literature women subject to NCS
experience worse quality of life, physical image and
satisfaction indicators than those undergoing CS
[37-39]. Thus the women living in areas with higher
NCS rates will presumably be in disadvantage to their
peers living in areas with high CS rates were they to suf-
fer breast cancer. This situation in areas with lower
socioeconomic level must be tackled through strategies
to increase effective early detection, particularly in a
country where women have universal access to screen-
ing and treatment, without any copayment.
Additional material
Additional file 1: Age-standardized rates of breast cancer surgery
and potential explanatory socioeconomic and supply factors, by
type of intervention and age-group. The file shows the different
analyses aimed to explore the relationship between standardized-rates of
mastectomy and, supply and demand factors potentially related to
variation.
Additional file 2: Multilevel analyses modelling. The file describes the
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